Observational studyInternational journal of clinical oncology2026
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.
Neal Shore et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.